ClinicalTrials.govpublic full text
A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma
pancreatic ductal carcinoma, pancreatic ductal adenocarcinoma (pda), pegylated recombinant human hyaluronidase (pegph20), nab-paclitaxel, gemcitabine, metastatic, stage iv, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 804500
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.